linsidomine has been researched along with glycerol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceppi, ED; Horton, RA; Knowles, RG; Titheradge, MA | 1 |
| An, Z; Cherrington, AD; Dardevet, DP; DiCostanzo, CA; Edgerton, DS; Moore, MC; Neal, DW | 1 |
| Cherrington, AD; Dicostanzo, CA; Farmer, B; Moore, MC; Neal, DW; Rodewald, TD; Smith, MS; Williams, PE | 1 |
3 other study(ies) available for linsidomine and glycerol
| Article | Year |
|---|---|
Inhibition of hepatic gluconeogenesis by nitric oxide: a comparison with endotoxic shock.
Topics: Animals; Dihydroxyacetone; Endotoxins; Fructose; Gluconeogenesis; Glycerol; Lactates; Liver; Male; Molsidomine; Nitric Oxide; Nitrites; Penicillamine; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Shock, Septic | 1994 |
Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
Topics: Animals; Blood Glucose; Blood Pressure; Carbon; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Heart Rate; Infusions, Intravenous; Insulin; Lactic Acid; Liver; Liver Circulation; Molsidomine; Nitric Oxide Donors; Portal Vein | 2008 |
Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
Topics: Animals; Blood Glucose; Carbon; Catheterization; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Nonesterified; Female; Glycerol; Hyperglycemia; Hyperinsulinism; Lactic Acid; Liver; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Portal Vein; Postprandial Period | 2008 |